Newsletter | February 7, 2023

02.07.23 -- How BMS Uses AI To Improve Study Design And Reduce Costs


Welcome to the Tuesday edition of the Clinical Leader newsletter, focusing on Clinical Trial TechnologyUpdate your topic preferences to receive additional Clinical Leader newsletters on:

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)
Webinar: Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations

Join Camila Matheny, DCT implementation expert, as she discusses the benefits of adopting consent management technology and provides best practices around developing change management and training programs to help sponsors, CROs, and sites get the most out of eConsent. Click here to learn more.

Clinical Trial Technology
How BMS Uses AI To Improve Study Design And Reduce Costs

In 2022, Bristol Myers Squibb (BMS) announced plans to work with AI developer Owkin to design and optimize cardiovascular drug trials. In this Q&A, Venkat Sethuraman, SVP, global biometrics and data sciences at BMS, discusses the partnership, the use of AI in cardiovascular trials, and how the technology will create a better patient experience.

Enabling Regulatory Support For eSource

Delve into an illustration of how robust EDC systems fully support the operational requirements introduced by the decision to leverage eSource data.

Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, And Integrations

Dive into six insights to stay on top of the rapidly shifting research industry and to ensure your research organization doesn’t get left behind. 

eSource Solutions Enable More Flexible Clinical Trials

Read about how remote data collection and telehealth practices have paved the way for more flexible clinical trial designs that collect data from sources beyond research site locations.

The Secret Sauce In Successful Clinical Trial Payments Programs

More than 80 percent of sites surveyed want to get paid in 30 days, and many clinical technology companies offer specialized software solutions to address the site payments process. However, these systems still require a large effort by the sponsor to operate. What is the secret sauce for success?

Simple And Cost-Effective Ways To Engage Patients Using eCOA And IRT

Patients are even more digital-savvy and exposed to sophisticated technology. This presents a huge opportunity to incorporate patient engagement into clinical trials and elevate patient engagement efforts in ongoing clinical trials.

eTMF For Clinical Trial Master Files And Operations

See how a modern eTMF system built with a new exchange standard promises to bring better collaboration and compliance.

IRT And e-Clinical Technology Considerations For Cell And Gene Therapy

At Cenduit, we never try to fit cell and gene therapy studies — or any kind of study — into predefined functionality. The Cenduit IRT and Quantum Interactive™ agile design platforms and reporting tools support clients’ most complex requirements.